{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:17:23Z","timestamp":1788967043743,"version":"build-2803163510"},"reference-count":88,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["302632"],"award-info":[{"award-number":["302632"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["210634"],"award-info":[{"award-number":["210634"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["223107"],"award-info":[{"award-number":["223107"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/W016613\/1"],"award-info":[{"award-number":["BB\/W016613\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","award":["BB\/R007195\/1"],"award-info":[{"award-number":["BB\/R007195\/1"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C35050\/A22284"],"award-info":[{"award-number":["C35050\/A22284"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.celrep.2026.117350","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T23:05:36Z","timestamp":1777935936000},"page":"117350","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["PARP1-specific inhibitor displays PARP1-detrapping activity"],"prefix":"10.1016","volume":"45","author":[{"given":"Kira","family":"Sch\u00fctzenhofer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Laker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domagoj","family":"Bareti\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin J.","family":"Suskiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian F.H.","family":"Zobel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.R.","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chatrin","family":"Chatrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9446-3756","authenticated-orcid":false,"given":"Ivan","family":"Ahel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2026.117350_bib1","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1016\/j.cell.2023.08.030","article-title":"ADP-ribosylation from molecular mechanisms to therapeutic implications","volume":"186","author":"Suskiewicz","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117350_bib2","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.molcel.2015.06.006","article-title":"PARPs and ADP-Ribosylation: 50 Years \u2026 and Counting","volume":"58","author":"Kraus","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2026.117350_bib3","doi-asserted-by":"crossref","first-page":"7399","DOI":"10.1111\/febs.16142","article-title":"ADP-ribosyltransferases, an update on function and nomenclature","volume":"289","author":"L\u00fcscher","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.celrep.2026.117350_bib4","doi-asserted-by":"crossref","first-page":"8217","DOI":"10.1093\/nar\/gkad514","article-title":"Updated protein domain annotation of the PARP protein family sheds new light on biological function","volume":"51","author":"Suskiewicz","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2026.117350_bib5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.dnarep.2018.08.022","article-title":"The comings and goings of PARP-1 in response to DNA damage","volume":"71","author":"Pascal","year":"2018","journal-title":"DNA Repair"},{"key":"10.1016\/j.celrep.2026.117350_bib6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.dnarep.2014.03.021","article-title":"Protein ADP-ribosylation and the cellular response to DNA strand breaks","volume":"19","author":"Caldecott","year":"2014","journal-title":"DNA Repair"},{"key":"10.1016\/j.celrep.2026.117350_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2025.103863","article-title":"PARPs and ADP-ribosyl hydrolases in cancer therapy: From drug targets to biomarkers","volume":"152","author":"Groslambert","year":"2025","journal-title":"DNA Repair"},{"key":"10.1016\/j.celrep.2026.117350_bib8","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.molcel.2017.01.003","article-title":"Serine ADP-Ribosylation Depends on HPF1","volume":"65","author":"Bonfiglio","year":"2017","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2026.117350_bib9","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.molcel.2016.03.008","article-title":"HPF1\/C4orf27 Is a PARP-1-Interacting Protein that Regulates PARP-1 ADP-Ribosylation Activity","volume":"62","author":"Gibbs-Seymour","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2026.117350_bib10","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.molcel.2015.06.012","article-title":"The Promise of Proteomics for the Study of ADP-Ribosylation","volume":"58","author":"Daniels","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2026.117350_bib11","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1021\/acs.biochem.7b00670","article-title":"Generation and Characterization of Recombinant Antibody-like ADP-Ribose Binding Proteins","volume":"56","author":"Gibson","year":"2017","journal-title":"Biochemistry"},{"key":"10.1016\/j.celrep.2026.117350_bib12","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.celrep.2018.07.083","article-title":"Systems-wide Analysis of Serine ADP-Ribosylation Reveals Widespread Occurrence and Site-Specific Overlap with Phosphorylation","volume":"24","author":"Larsen","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2026.117350_bib13","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/nchembio.2180","article-title":"Serine is a new target residue for endogenous ADP-ribosylation on histones","volume":"12","author":"Leidecker","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.celrep.2026.117350_bib14","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1038\/s41467-024-48314-0","article-title":"Preserving ester-linked modifications reveals glutamate and aspartate mono-ADP-ribosylation by PARP1 and its reversal by PARG","volume":"15","author":"Longarini","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.117350_bib15","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/356356a0","article-title":"Role of poly(ADP-ribose) formation in DNA repair","volume":"356","author":"Satoh","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117350_bib16","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41594-023-00977-x","article-title":"HPF1-dependent histone ADP-ribosylation triggers chromatin relaxation to promote the recruitment of repair factors at sites of DNA damage","volume":"30","author":"Smith","year":"2023","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.celrep.2026.117350_bib17","doi-asserted-by":"crossref","first-page":"6675","DOI":"10.1038\/s41467-021-27043-8","article-title":"HPF1 dynamically controls the PARP1\/2 balance between initiating and elongating ADP-ribose modifications","volume":"12","author":"Langelier","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.117350_bib18","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.34334","article-title":"Serine is the major residue for ADP-ribosylation upon DNA damage","volume":"7","author":"Palazzo","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.celrep.2026.117350_bib19","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.65773","article-title":"HPF1 and nucleosomes mediate a dramatic switch in activity of PARP1 from polymerase to hydrolase","volume":"10","author":"Rudolph","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.celrep.2026.117350_bib20","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41586-020-2013-6","article-title":"HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation","volume":"579","author":"Suskiewicz","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117350_bib21","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1016\/j.molcel.2021.04.028","article-title":"Unrestrained poly-ADP-ribosylation provides insights into chromatin regulation and human disease","volume":"81","author":"Prokhorova","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2026.117350_bib22","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1038\/ncomms3164","article-title":"Visualization of poly(ADP-ribose) bound to PARG reveals inherent balance between exo- and endo-glycohydrolase activities","volume":"4","author":"Barkauskaite","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.117350_bib23","doi-asserted-by":"crossref","first-page":"11895","DOI":"10.1074\/jbc.272.18.11895","article-title":"Isolation and characterization of the cDNA encoding bovine poly(ADP-ribose) glycohydrolase","volume":"272","author":"Lin","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.celrep.2026.117350_bib24","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nature10404","article-title":"The structure and catalytic mechanism of a poly(ADP-ribose) glycohydrolase","volume":"477","author":"Slade","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117350_bib25","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.28533","article-title":"Serine ADP-ribosylation reversal by the hydrolase ARH3","volume":"6","author":"Fontana","year":"2017","journal-title":"eLife"},{"key":"10.1016\/j.celrep.2026.117350_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113113","article-title":"The interplay of TARG1 and PARG protects against genomic instability","volume":"42","author":"Groslambert","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2026.117350_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107838","article-title":"Reversal of tyrosine-linked ADP-ribosylation by ARH3 and PARG","volume":"300","author":"Rack","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.celrep.2026.117350_bib28","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/emboj.2013.51","article-title":"Deficiency of terminal ADP-ribose protein glycohydrolase TARG1\/C6orf130 in neurodegenerative disease","volume":"32","author":"Sharifi","year":"2013","journal-title":"Embo j"},{"key":"10.1016\/j.celrep.2026.117350_bib29","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1126\/science.1177321","article-title":"Poly(ADP-ribose)-dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1","volume":"325","author":"Ahel","year":"2009","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.celrep.2026.117350_bib30","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1042\/BST20180418","article-title":"PARPs in genome stability and signal transduction: implications for cancer therapy","volume":"46","author":"Palazzo","year":"2018","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.celrep.2026.117350_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105397","article-title":"ADP-ribose contributions to genome stability and PARP enzyme trapping on sites of DNA damage; paradigm shifts for a coming-of-age modification","volume":"299","author":"Rouleau-Turcotte","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.celrep.2026.117350_bib32","first-page":"9279","article-title":"Poly(ADP-ribose) polymerases covalently modify strand break termini in DNA fragments in vitro","volume":"44","author":"Talhaoui","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2026.117350_bib33","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41594-024-01279-6","article-title":"Deregulated DNA ADP-ribosylation impairs telomere replication","volume":"31","author":"Wondisford","year":"2024","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.celrep.2026.117350_bib34","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/nature03443","article-title":"Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase","volume":"434","author":"Bryant","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117350_bib35","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1158\/0008-5472.CAN-12-2753","article-title":"Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors","volume":"72","author":"Murai","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2026.117350_bib36","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03445","article-title":"Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy","volume":"434","author":"Farmer","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117350_bib37","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1158\/1541-7786.MCR-15-0191-T","article-title":"Mechanistic Dissection of PARP1 Trapping and the Impact on In Vivo Tolerability and Efficacy of PARP Inhibitors","volume":"13","author":"Hopkins","year":"2015","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.celrep.2026.117350_bib38","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1158\/1535-7163.MCT-13-0803","article-title":"Stereospecific PARP trapping by BMN 673 and comparison with olaparib and rucaparib","volume":"13","author":"Murai","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.celrep.2026.117350_bib39","doi-asserted-by":"crossref","first-page":"9694","DOI":"10.1093\/nar\/gkaa718","article-title":"Clinical PARP inhibitors do not abrogate PARP1 exchange at DNA damage sites in vivo","volume":"48","author":"Shao","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2026.117350_bib40","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2301972120","article-title":"Inactive PARP1 causes embryonic lethality and genome instability in a dominant-negative manner","volume":"120","author":"Shao","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117350_bib41","doi-asserted-by":"crossref","first-page":"7665","DOI":"10.1093\/nar\/gkm933","article-title":"Feedback-regulated poly(ADP-ribosyl)ation by PARP-1 is required for rapid response to DNA damage in living cells","volume":"35","author":"Mortusewicz","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2026.117350_bib42","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2322689121","article-title":"Histone ADP-ribosylation promotes resistance to PARP inhibitors by facilitating PARP1 release from DNA lesions","volume":"121","author":"Zentout","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117350_bib43","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1038\/s41467-021-24361-9","article-title":"Serine-linked PARP1 auto-modification controls PARP inhibitor response","volume":"12","author":"Prokhorova","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.117350_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb8626","article-title":"The chromatin remodeler ALC1 underlies resistance to PARP inhibitor treatment","volume":"6","author":"Juh\u00e1sz","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.celrep.2026.117350_bib45","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.molonc.2011.07.001","article-title":"The underlying mechanism for the PARP and BRCA synthetic lethality: clearing up the misunderstandings","volume":"5","author":"Helleday","year":"2011","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.celrep.2026.117350_bib46","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41586-024-07217-2","article-title":"Transcription-replication conflicts underlie sensitivity to PARP inhibitors","volume":"628","author":"Petropoulos","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117350_bib47","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/s41556-021-00792-w","article-title":"XRCC1 protects transcription from toxic PARP1 activity during DNA base excision repair","volume":"23","author":"Adamowicz","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.celrep.2026.117350_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/cells8121625","article-title":"The Enigmatic Function of PARP1: From PARylation Activity to PAR Readers","volume":"8","author":"Kamaletdinova","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.celrep.2026.117350_bib49","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1056\/NEJMoa1909707","article-title":"Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer","volume":"381","author":"Coleman","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2026.117350_bib50","doi-asserted-by":"crossref","first-page":"4724","DOI":"10.1158\/1078-0432.CCR-22-0301","article-title":"Preclinical Characterization of AZD5305, A Next-Generation, Highly Selective PARP1 Inhibitor and Trapper","volume":"28","author":"Illuzzi","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2026.117350_bib51","article-title":"PARP Inhibitors: Clinical Limitations and Recent Attempts to Overcome Them","volume":"23","author":"Kim","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.celrep.2026.117350_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114234","article-title":"A unified mechanism for PARP inhibitor-induced PARP1 chromatin retention at DNA damage sites in living cells","volume":"43","author":"Kanev","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.celrep.2026.117350_bib53","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2121979119","article-title":"Inhibitors of PARP: Number crunching and structure gazing","volume":"119","author":"Rudolph","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117350_bib54","doi-asserted-by":"crossref","DOI":"10.1126\/science.aax6367","article-title":"Structural basis for allosteric PARP-1 retention on DNA breaks","volume":"368","author":"Zandarashvili","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.celrep.2026.117350_bib55","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1021\/acs.biochem.3c00243","article-title":"Slow Dissociation from the PARP1-HPF1 Complex Drives Inhibitor Potency","volume":"62","author":"Stojanovic","year":"2023","journal-title":"Biochemistry"},{"key":"10.1016\/j.celrep.2026.117350_bib56","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41571-021-00532-x","article-title":"Understanding and overcoming resistance to PARP inhibitors in cancer therapy","volume":"18","author":"Dias","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.celrep.2026.117350_bib57","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/cdd.2014.202","article-title":"PARP-2 sustains erythropoiesis in mice by limiting replicative stress in erythroid progenitors","volume":"22","author":"Farr\u00e9s","year":"2015","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.celrep.2026.117350_bib58","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1182\/blood-2012-12-472845","article-title":"Parp-2 is required to maintain hematopoiesis following sublethal \u03b3-irradiation in mice","volume":"122","author":"Farr\u00e9s","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.celrep.2026.117350_bib59","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/s41467-018-03159-2","article-title":"PARP1 and PARP2 stabilise replication forks at base excision repair intermediates through Fbh1-dependent Rad51 regulation","volume":"9","author":"Ronson","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.117350_bib60","doi-asserted-by":"crossref","first-page":"14498","DOI":"10.1021\/acs.jmedchem.1c01012","article-title":"Discovery of 5-{4-[(7-Ethyl-6-oxo-5,6-dihydro-1,5-naphthyridin-3-yl)methyl]piperazin-1-yl}-N-methylpyridine-2-carboxamide (AZD5305): A PARP1\u2013DNA Trapper with High Selectivity for PARP1 over PARP2 and Other PARPs","volume":"64","author":"Johannes","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.celrep.2026.117350_bib61","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1158\/1078-0432.CCR-23-2094","article-title":"Preclinical Characterization of AZD9574, a Blood-Brain Barrier Penetrant Inhibitor of PARP1","volume":"30","author":"Staniszewska","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2026.117350_bib62","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1089\/hum.1998.9.13-1939","article-title":"Tetracycline repressor, tetR, rather than the tetR-mammalian cell transcription factor fusion derivatives, regulates inducible gene expression in mammalian cells","volume":"9","author":"Yao","year":"1998","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.celrep.2026.117350_bib63","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1093\/nar\/gkz120","article-title":"Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins","volume":"47","author":"Alemasova","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2026.117350_bib64","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1074\/jbc.270.7.3247","article-title":"Role of glutamic acid 988 of human poly-ADP-ribose polymerase in polymer formation. Evidence for active site similarities to the ADP-ribosylating toxins","volume":"270","author":"Marsischky","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.celrep.2026.117350_bib65","doi-asserted-by":"crossref","first-page":"12147","DOI":"10.1021\/bi971055p","article-title":"Random mutagenesis of the poly(ADP-ribose) polymerase catalytic domain reveals amino acids involved in polymer branching","volume":"36","author":"Rolli","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.celrep.2026.117350_bib66","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.1021\/ja412897a","article-title":"Engineering the substrate specificity of ADP-ribosyltransferases for identifying direct protein targets","volume":"136","author":"Carter-O'Connell","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.celrep.2026.117350_bib67","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1006\/jmbi.1998.1673","article-title":"The mechanism of the elongation and branching reaction of poly(ADP-ribose) polymerase as derived from crystal structures and mutagenesis","volume":"278","author":"Ruf","year":"1998","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.celrep.2026.117350_bib68","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3389\/fonc.2013.00301","article-title":"Structural Implications for Selective Targeting of PARPs","volume":"3","author":"Steffen","year":"2013","journal-title":"Front. Oncol."},{"key":"10.1016\/j.celrep.2026.117350_bib69","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S1470-2045(14)70228-1","article-title":"Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial","volume":"15","author":"Ledermann","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.celrep.2026.117350_bib70","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1021\/acs.jmedchem.6b00990","article-title":"Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors","volume":"60","author":"Thorsell","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.celrep.2026.117350_bib71","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.molcel.2018.06.004","article-title":"The Importance of Poly(ADP-Ribose) Polymerase as a Sensor of Unligated Okazaki Fragments during DNA Replication","volume":"71","author":"Hanzlikova","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2026.117350_bib72","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.dnarep.2014.04.008","article-title":"DNA-PK phosphorylation of RPA32 Ser4\/Ser8 regulates replication stress checkpoint activation, fork restart, homologous recombination and mitotic catastrophe","volume":"21","author":"Ashley","year":"2014","journal-title":"DNA Repair"},{"key":"10.1016\/j.celrep.2026.117350_bib73","doi-asserted-by":"crossref","first-page":"10780","DOI":"10.1093\/nar\/gks849","article-title":"Distinct roles for DNA-PK, ATM and ATR in RPA phosphorylation and checkpoint activation in response to replication stress","volume":"40","author":"Liu","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2026.117350_bib74","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adf7175","article-title":"Clinical PARP inhibitors allosterically induce PARP2 retention on DNA","volume":"9","author":"Langelier","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.celrep.2026.117350_bib75","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.molcel.2015.10.013","article-title":"PARP-1 Activation Requires Local Unfolding of an Autoinhibitory Domain","volume":"60","author":"Dawicki-McKenna","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.celrep.2026.117350_bib76","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1126\/science.1216338","article-title":"Structural basis for DNA damage-dependent poly(ADP-ribosyl)ation by human PARP-1","volume":"336","author":"Langelier","year":"2012","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.celrep.2026.117350_bib77","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abq0414","article-title":"A two-step mechanism governing PARP1-DNA retention by PARP inhibitors","volume":"8","author":"Xue","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.celrep.2026.117350_bib78","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.1158\/0008-5472.CAN-21-3201","article-title":"PARP Inhibitors - Trapped in a Toxic Love Affair","volume":"81","author":"Krastev","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2026.117350_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2024.103775","article-title":"Positioning loss of PARP1 activity as the central toxic event in BRCA-deficient cancer","volume":"144","author":"MacGilvary","year":"2024","journal-title":"DNA Repair"},{"key":"10.1016\/j.celrep.2026.117350_bib80","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/s41589-019-0379-2","article-title":"Uncoupling of PARP1 trapping and inhibition using selective PARP1 degradation","volume":"15","author":"Wang","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.celrep.2026.117350_bib81","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.cell.2008.12.042","article-title":"The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling cascade at sites of DNA damage","volume":"136","author":"Stewart","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117350_bib82","first-page":"2546","article-title":"Overlapping roles for PARP1 and PARP2 in the recruitment of endogenous XRCC1 and PNKP into oxidized chromatin","volume":"45","author":"Hanzlikova","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2026.117350_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2005970","article-title":"CellProfiler 3.0: Next-generation image processing for biology","volume":"16","author":"McQuin","year":"2018","journal-title":"PLoS Biol."},{"key":"10.1016\/j.celrep.2026.117350_bib84","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.celrep.2026.117350_bib85","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092444","article-title":"ColonyArea: an ImageJ plugin to automatically quantify colony formation in clonogenic assays","volume":"9","author":"Guzm\u00e1n","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2026.117350_bib86","doi-asserted-by":"crossref","first-page":"6319","DOI":"10.1038\/s41467-025-61111-7","article-title":"Identification of RNF114 as ADPr-Ub reader through non-hydrolysable ubiquitinated ADP-ribose","volume":"16","author":"Kloet","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.117350_bib87","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117350_bib88","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"}],"updated-by":[{"DOI":"10.1016\/j.celrep.2026.117466","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000}}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726004286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726004286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T08:58:31Z","timestamp":1783155511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124726004286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":88,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2211124726004286"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2026.117350","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PARP1-specific inhibitor displays PARP1-detrapping activity","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2026.117350","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117350"}}